Northern Light Venture Capital
VC Fund
Beijing, China
Northern Light Venture Capital is a VC fund in Beijing focused on Health Care and Medical. Northern Light Venture Capital was founded by general partners Feng Deng and Yan Ke on January 1, 2005. Currently it is managed by five Managing Directors. It manages approximately US$ 1.5 billion in committed capital with 4 US$ funds and 4 RMB funds, investing in more than 180 portfolio companies and seed investments to date. NLVC is led by a partnership of accomplished local Chinese and ""returnee"" executives (""returnees"" are those who grew up in mainland China but studied or worked abroad before returning) with significant investing and entrepreneurial accomplishments. Its management team includes Feng Deng, former member of the board at NetScreen (a pioneering IT security firm), Yan Ke, vice President of Netscreen, and Lei Yang, chairman of Vantage Point Venture Partners. NLVC is a China concept venture capital firm focused on early and growth stage opportunities which targets businesses that leverage China’s industrial, economic, or human resources to build exceptional, lasting enterprises in the global economy. NLVC focuses on early and growth stage opportunities in information technology, new media, TMT, clean technologies, consumer service and healthcare. Portfolio companies include Meituan.com, Kaixin001.com, Gogo.com, redbaby.com, MasaMaso.com, and Velo City.
- Total investments:
- 400
- Last investment:
- Lead investor:
- 27%
- Fund size:
- $375M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Northern Light Venture Capital invests in
Stages Northern Light Venture Capital invests in
Countries Northern Light Venture Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 12 contacts → | |||
Round size
- Series A
- $2.9M–$40M
- Series B
- $8.8M–$56M
- Venture - Series Unknown
- $1.5M–$60M
Investment Focus
Industry
- Health Care 59 (15%)
- Medical 46 (12%)
- Biotechnology 43 (11%)
- Manufacturing 36 (9%)
- Information Technology 31 (8%)
Stage
- Series A 99 (25%)
- Series B 85 (21%)
- Venture - Series Unknown 54 (14%)
- Seed 44 (11%)
- Angel 32 (8%)
Country
- China 239 (60%)
- United States 39 (10%)
- South Korea 7 (2%)
- Singapore 2 (1%)
- Germany 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Figo Zhang
Partner
|
Partner | Total investments: 1 | Find email | |
Feng Deng
Founding General Partner
|
Founding General Partner | Total investments: 30 | Find email | |
Lixin Li
Managing Director
|
Managing Director | Total investments: 2 | Find email | |
Lu Lin
Executive Director
|
Executive Director | Total investments: 2 | Find email | |
Pandy Song
Associate
|
Associate | Total investments: 0 | Find email | |
| See all 12 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Yige Cloud is a zero-trust enterprise network security solution provider. The company SASE serves network and security capabilities and integrates them into a cloud-native service platform to provide integrated network and security functions, realize threat detection and fine-grained access control across the enterprise, and ensure user experienceand security when accessing applications. It provides integrated security services (such as threat prevention, web filtering, sandboxing, DNS security, data leakage prevention, and next-generation firewall policies), ensuring zero-trust access to the network. | $14.9M / Series B / Sep 14, 2026 | ||
| Inno Pharmaceutical Technology specializes in research on the pathogenesis of atherosclerosis. The company focuses on the development of targeted nanoliposomes, targeting molecules with independent intellectual property rights, and currently focuses on the plaque reversal treatment of atherosclerosis. | $119.2M / Series D / Sep 09, 2026 | ||
| Noiz AI is a product that offers highly expressive, lifelike speech synthesis, leading the industry in cost, efficiency, and customization. Use cases include TTS, voice cloning, video dubbing, and video translation. | Seed / Aug 10, 2026 | ||
SuperMagnetic New Energy
|
SuperMagnetic New Energy is a cutting-edge innovation center and engineering incubator. | Angel / Jun 29, 2026 | |
| Blue Pivot Energy Technology is a nuclear energy technology company focused on the independent development and commercialization of integrated water-cooled small modular reactors (SMRs). | Seed / Jun 11, 2026 | ||
|
SuperMagnetic New Energy
|
SuperMagnetic New Energy is a cutting-edge innovation center and engineering incubator. | Angel / Jan 16, 2026 | |
Vibrant
|
Vibrant develops an AI drug development platform to focus on building immune system-related drug pipelines. The company will use artificial intelligence algorithms to accelerate the efficiency of drug development in various aspects such as target discovery, drug design, and drug efficacy evaluation; at the same time, the company expects tocontinuously improve the success rate of drug development through sustainable data accumulation and algorithm optimization.It was founded and headed by Dr. Wang Luquan and is based in Guangzhou, Guangdong, China. | $61M / Jan 12, 2026 | |
| Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment. The company offers a drug-free approach to controlling severe, chronic airway diseases through its Spiro Neuromodulation System. | $67M / Series A / Jan 07, 2026 | ||
| BV Laser is a manufacturer of medical beauty equipment. | $14.2M / Series C / Dec 15, 2025 | ||
|
Sanegene Bio
|
Sanegene Bio is currently operating in stealth mode. | $110M / Series B / Dec 08, 2025 | |
| See all 400 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Northern Light Venture Capital invest in?
Northern Light Venture Capital invests primarily in Health Care, Medical and Biotechnology startups, most often at Series A and Series B stage. Most of the 400 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Northern Light Venture Capital invest in?
Northern Light Venture Capital typically joins rounds of $2.9M–$40M at Series A, $8.8M–$56M at Series B and $1.5M–$60M at Venture - Series Unknown. These are whole funding-round sizes, not Northern Light Venture Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Northern Light Venture Capital took part in.
How do I contact Northern Light Venture Capital?
Public channels for Northern Light Venture Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Northern Light Venture Capital?
The team at Northern Light Venture Capital includes Figo Zhang (Partner), Feng Deng (Founding General Partner) and Lixin Li (Managing Director), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
